Zentalis Pharmaceuticals Inc (ZNTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Operating Expenses | 118,787 | 46,845 | 0 | 0 |
| Operating Income | -118,787 | -46,845 | N/A | N/A |
| Other Income | 683 | 482 | 0 | 0 |
| Pre-tax Income | -118,104 | -46,363 | 0 | 0 |
| Income Tax | 444 | 15 | N/A | N/A |
| Net Income Continuous | -118,548 | -46,378 | N/A | N/A |
| Minority Interests | -707 | -715 | N/A | N/A |
| Net Income | $-117,841 | $-45,663 | $N/A | $N/A |
| EPS Basic Total Ops | -4.19 | -8.16 | N/A | N/A |
| EPS Basic Continuous Ops | -4.22 | -8.29 | N/A | N/A |
| EPS Diluted Total Ops | -4.19 | -8.16 | N/A | N/A |
| EPS Diluted Continuous Ops | -4.22 | -8.29 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -4.19 | N/A | N/A | N/A |
| EBITDA(a) | $-118,071 | $-46,734 | $N/A | $N/A |